Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
3164:TPE
GenMont Biotech Inc
NT$16.80
+0.90%
(+0.15) 1D
May 22, 1:30:24 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 3164...
Open
NT$16.85
High
NT$16.85
Low
NT$16.45
Mkt. cap
1.44B
Avg. vol.
66.42K
Volume
164.10K
Dividend
4.76%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
32.31
52-wk high
NT$22.40
52-wk low
NT$16.45
EPS
NT$0.52
Shares outstanding
88.91M
No. of employees
147
News stories
From sources across the web
About GenMont Biotech Inc
CEO-
Employees147
Founded2000
Headquarters-
SectorBiotechnology
Websitegenmont.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
112.17M
88.90M
100.70M
89.17M
Cost of goods sold
41.30M
33.41M
38.03M
40.95M
Cost of revenue
41.30M
33.41M
38.03M
40.95M
Research and development expenses
10.93M
11.02M
11.62M
10.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.68M
37.01M
38.04M
35.28M
Operating expense
43.32M
46.77M
50.91M
55.40M
Total operating expenses
84.62M
80.18M
88.94M
96.35M
Operating income
27.56M
8.72M
11.76M
-7.18M
Other non operating income
164.00K
586.00K
374.00K
9.88M
EBT including unusual items
-12.96M
28.68M
29.47M
3.38M
EBT excluding unusual items
-12.04M
23.39M
29.47M
3.38M
Income tax expense
-2.15M
6.38M
7.16M
1.58M
Effective tax rate
16.62%
22.26%
24.31%
46.60%
Other operating expenses
-
-
-
9.64M
Net income
-8.74M
24.68M
24.80M
4.15M
Net profit margin
-7.79%
27.76%
24.62%
4.65%
Earnings per share
-
-
-
-
Interest and investment income
1.58M
1.74M
1.55M
1.62M
Interest expense
-977.00K
-953.00K
-900.00K
-937.00K
Net interest expenses
605.00K
784.00K
651.00K
685.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
43.11M
24.07M
27.26M
10.10M
Gain or loss from assets sale
-
-
1.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer